Background: Methicillin-resistant Staphylococcus aureus (MRSA) which causes nosocomial infections is among the most important multi-resistant pathogens worldwide. Investigations of MRSA outbreaks in nosocomial settings often require strain-typing data to verify effectively that the isolates belong to the outbreak strain, and to discriminate similarity from unsimilarity strains. Quick and reliable typing methods are required to obtain information among MRSA isolates and to allow faster implementation of appropriate control measures. Objective : The aim of this study was to investigate genotyping of methicillin resistant and sensitive Staphylococcus aureus (MRSA and MSSA) in Khartoum Teaching Hospital, Sudan by using antibiotype and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) of the coagulase gene. Methods: This is across sectional study. The samples were collected from clinical wound specimens in the wards of surgery, orthopaedic and burns at Khartoum Teaching Hospital, then processed, cultured and subsequently susceptibility test was performed using disc diffusion method. The MRSA strains were investigated by oxacillin 1[g disk diffusion method. PCR used to amplify a sequence of the coagulase (coa) gene, and the PCR products were analyzed by PCR-RFLP using Alu1 restriction enzyme. Result: Forty eight S. aureus strains were isolated and the number of MRSA identified was 9(18.75%). All strains of MRSA and MSSA were sensitive to vancomycin, while multi-drug resistance was common among MRSA strains. PCR amplification products of coa gene were approximately at 500 bp (26/48), and 580 bp (22/48). By Alu1 restriction enzyme digestion of the PCR-amplified of coagulase gene, two distinct PCR-RFLP patterns exhibited; coaA and coaB and their fragments were approximately at 190, 310 bp and 190, 390 bp with percentages of 54.2% (26/48) and 45.8% (22/48) respectively. Conclusion: PCR-RFLP is considered an attractive tool for rapidly demonstrate the frequency of different patterns and discriminate the relatedness of isolates in different hospital wards.
taphylococcus aureus has long been recognized as being an important pathogen in human disease. Serious staphylococcal infections can frequently occur in patients and may lead to dire consequences, especially for therapy with antimicrobial agents 1 . Outbreaks of hospital acquired infections due to methicillin resistant S. aureus (MRSA) are being reported with increasing frequency, challenging clinicians Correspondence: Dr. Eidha A. Bin Hameed, Hadhramout University of Sciences and Technology. Yemen. Tel. +967770847208. E-mail: eidha6@hotmail.com and infection control teams throughout the world 2 . Phenotypic markers can be used to identify MRSA. The antibiogram has been the main typing tool in many hospital outbreaks since the technique is widely available and standardized, and it can be used with all microbial species 3 . Coagulase production is the principal criterion used by the clinical microbiology laboratory for the identification of S. aureus isolates from human infections 4 . Besides the traditional typing methods for MRSA, several alternative molecular techniques have been developed for epidemiological studies.
S
Among these are pulsed-field gel electrophoresis (PFGE) 3 , polymerase chain reaction (PCR) of the coagulase (coa) gene, the protein A (spa) gene, hypervariable regions (HVR) adjacent to the mecA gene 5,6. DNA sequencing and polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) of the coa and spa genes 7 . The PCR amplifications of these particular regions produce DNA fragments of different sizes and are highly polymorphic with regard to the number and sequence of the repeats 8 . Investigation of staphylococcal isolates (MRSA and MSSA) outbreak in nosocomial settings often requires strain-typing data to verify effectively that the isolates belong to the outbreak and discriminate similarity from unsimilarity strains. Therefore, the aim of this study was to investigate the epidemiological typing of S. aureus isolates from Khartoum Teaching Hospital by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) of the coagulase (coa) gene. (5 [g) . A suspension of the tested organisms was adjusted against 0.5 MacFarland standard turbidity and inoculated onto media, then incubated at 35-37 °C for 16-18 hours, and examined for evidence of growth.
Materials and Methods

The
Stock clinical cultures were maintained in brain heart infusion broth-glycerol mixture (3:1 vol/vol) at -70ºC until further molecular analysis 2 . Genomic DNA was isolated by using chloroform DNA purification protocol. With a 1µl loop, a small quantity of growth equivalent to about two small colonies was scraped from the top of the culture and placed into 100µl of sterile distilled water in a microcentrifuge tube. Chloroform 100µl (Sigma) was added, and the mixture was vortexed for about 10 seconds. The mixture was heated at 80°C for 20 minutes, after which time it was held at -20°C for at least 20 minutes. The sample was allowed to thaw but while still cold was centrifuged at 12,000xg for 3 minutes in a minicentrifuge. The DNA was stored at -20°C and ready for use 9 .
The coa gene was amplified with two primers, as described by 8 . The forward primer 5j-ATA GAG ATG CTG GTA CAG G-3j (1513 to 1531) and the reverse primer 5j-GCT TCC GAT TGT TCG ATG C-3j (2188 to 2168) were chosen. The PCR reaction mixture contained of reaction buffer (5µl), 500U Go Taq DNA polymerase (0.5µl) (Promega), 10mM dNTPs mix (1µl), 25mM MgCl 2 (3µl), 10PM forward primer (12µl), 10PM reverse primer (8.8µl), template DNA (5µl), and distilled water (14.7µl) to a final volume 50µl. DNA amplifications were performed in thermal cycles as the following cycling parameters: an initial step at 94°C for 3 minutes; 30 cycles of 94°C for 1 minute, 55°C for 1 minute, and 72°C for 1 minute; and a final step at 72°C for 4 minutes. The PCR-amplified samples were subjected to electrophoresis on 0.8% agarose gel with ethidium bromide incorporated for DNA staining. The PCR products were visualized and photographed on an UV transilluminator, and the sizes of the PCR products were determined by comparison to 100-1000 ladder DNA marker (Sigma).
After amplification, ten microliters of PCR product was mixed and digested with 2 units (0.2µl) of restriction endonuclease AluI (Promega) at 37°C for 1 hr 30 minutes. The restriction digested fragments were electrophoresis on 1% agarose gel, which were visualized under UV light. Photographs of agarose gel were taken using gel documentation system, and the pictures were further analyzed with computer and printed.
Results
Forty eight S. aureus isolates were collected and the number of MRSA identified was 9(18.75%). All isolates were classified into 3 groups; group k: S. aureus isolated from surgical ward (No. = 28; 58.3%), group kk: S. aureus isolated from orthopaedic ward (No. = 14; 29.2%), and group kkk: S. aureus isolated from burns unit (No. = 6; 12.5%).
The susceptibility test was conducted for 48 S. aureus isolates against 10 antimicrobial agents by disc diffusion method. All isolates showed 100% sensitivity to vancomycin. For the other antibiotics, the degree of sensitivity was; co-trimoxazole 27 (56.25%), rifampicin 35 (72.9%), clindamycin 33 (68.75%), tetracycline 16 (33.3%), erythromycin 31 (64.6%), cephalexine 29 (60.4%), methicillin 39 (81.25%), amoxicillin 19 (39.6%), and ciprofloxacin 32 (66.7%).
All 48 S. aureus isolates examined produced PCR amplicon when coagulase gene primers were used. The two PCR size products obtained were approximately at 500 bp (26 isolates), and 580 bp (22 isolates). An isolate of CoNS (S. epidermidis) and Escherichia coli which served as negative controls produced no DNA product following PCR amplification (Fig. 1) .
PCR products from coagulase gene specific primers were digested with AluI restriction enzyme, and the resulting fragments were separated by gel electrophoresis. Two distinct patterns were detected among S. aureus isolates; coaA and coaB with sizes approximately at 190, 310 bp and 190, 390 bp. The percentages of these patterns were 54.2% and 45.8% respectively (Fig. 2) . 
Discussion
The objective of this study was to determine whether PCR-RFLP of the coagulase gene could be used to differentiate the similarity or unsimilarity between the tested isolates. The coagulase gene from 48 isolates was amplified by PCR, and the products were digested with endonuclease enzyme AluI. Therefore, PCR-RFLP analysis showed that two different restriction profile patterns coaA, and coaB, could be identified according to their PCR end products at 190, 310 bp and 190, 390 bp respectively. The use of DNA restriction endonuclease to digest the coagulase gene was beneficial in confirming the two distinct RFLP patterns among S. aureus strains. In addition, PCR-RFLP pattern analysis allowed the differentiation of isolates (Fig. 2) . The prevalence of different patterns in different hospital wards could be demonstrated, as well as the similarity or unsimilarity between the tested isolates.
Coagulase is produced by all strains of S. aureus, its production is the principal criterion used in the clinical microbiology laboratory for the identification of S. aureus in human infections, and it is thought to be an important virulence factor 10 . The coa gene coding for the coagulase protein has been considered a candidate for the development of DNA-based diagnostic assays for S. aureus. We presented evidence of existence type of coagulase gene among 48 S. aureus strains examined by PCR, and the products generated size variations in the amplicon primer. We found two size products obtained approximately at 500 bp and 580 bp of PCRcoagulase gene, because this gene is highly polymorphic. Numerous allelic forms of S. aureus coagulase exist, with each isolate producing one or more of these enzyme variants. By digestion with AluI restriction enzyme of the amplified gene product, it is possible to discriminate between S. aureus isolates by RFLP of the coagulase gene 4 . Therefore, the main purpose of present study was to establish a rapid and reliable molecular typing method for S. aureus by means of PCR-RFLP of coagulase gene, and this was accomplished within a single PCR-coagulase gene following amplimer digestion with AluI that resulted in reproducible restriction patterns and allowed sufficient discrimination among strains isolated from Khartoum Teaching Hospital. For RFLP coagulase gene typing, two distinct patterns were detected, and the number of fragments produced upon AluI digestion were two bands. These results differ from previous studies in which AluI PCR-RFLP fragments varied from one to four bands using the same primer sequences 8, 10 . However, other studies with different primer sequence of coa gene showed AluI PCR-RFLP fragments varied from two to three bands 4, 11 .
In this study we found that the coaA pattern was common in multiple antibiotic resistance strains MRSA and MSSA, and the DNA sequence differences in the staphylocoagulase gene are responsible for the polymorphic restriction fragment length patterns seen among the S. aureus isolates. The reason for this polymorphism in the coagulase gene among S. aureus strains is unclear, but the extensive polymorphism observed does suggest that the coagulase gene may be an important virulence determinant for this organism 4 . The coagulase gene RFLP method for typing of S. aureus isolates is far simpler than those previously reported. It requires only small quantities of crude DNA, and individual strains can be compared easily by both the number of PCR-amplified gene products and the sizes of their AluI restriction enzyme digest fragments. However, the coagulase gene typing has been reported to be a new attractive method for clinical laboratories because of its ease and speed 4 .
Conclusion
Restriction analysis by PCR-RFLP permitted discrimination of the tested strains by exhibiting specific PCR-RFLP patterns, and we could rapidly demonstrate the prevalence of different patterns in different hospital wards between the tested isolates. Therefore, PCR-RFLP represents a powerful, rapid and reliable molecular typing system as well as an alternative tool for routine epidemiological surveillance and infection control measures.
